Literature DB >> 17588163

Multi-modality imaging for assessment of myocardial viability?

Eliana Reyes.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17588163     DOI: 10.1007/s10554-007-9242-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  17 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

2.  Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization.

Authors:  Jeroen J Bax; Jamshid Maddahi; Don Poldermans; Abdou Elhendy; Jan H Cornel; Eric Boersma; Jos R T C Roelandt; Paolo M Fioretti
Journal:  J Nucl Med       Date:  2002-06       Impact factor: 10.057

3.  Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients.

Authors:  Claudia Ypenburg; Martin J Schalij; Gabe B Bleeker; Paul Steendijk; Eric Boersma; Petra Dibbets-Schneider; Marcel P M Stokkel; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur Heart J       Date:  2006-11-22       Impact factor: 29.983

4.  Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI.

Authors:  Assuero Giorgetti; Alessandro Pingitore; Brunella Favilli; Annette Kusch; Massimo Lombardi; Paolo Marzullo
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

5.  Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome.

Authors:  H Samady; J A Elefteriades; B G Abbott; J A Mattera; C A McPherson; F J Wackers
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

6.  Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium.

Authors:  R J Oudiz; D E Smith; A J Pollak; I Mena; S M Shapiro; L E Ginzton; K A Narahara
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

7.  Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium.

Authors:  G La Canna; S H Rahimtoola; O Visioli; R Giubbini; O Alfieri; M Zognio; E Milan; C Ceconi; M Gargano; R Lo Russo; R Ferrari
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

8.  Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction.

Authors:  A Pasquet; A Robert; A M D'Hondt; R Dion; J A Melin; J L Vanoverschelde
Journal:  Circulation       Date:  1999-07-13       Impact factor: 29.690

9.  Sestamibi SPECT in the detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction: comparison between visual and quantitative analysis.

Authors:  W Acampa; M Petretta; L Florimonte; M S di Santolo; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

10.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

Authors:  Anja Wagner; Heiko Mahrholdt; Thomas A Holly; Michael D Elliott; Matthias Regenfus; Michele Parker; Francis J Klocke; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.